Ara
Toplam kayıt 1583, listelenen: 1481-1490
Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer
(Lippincott Williams & Wilkins, 2023)
...
KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
(Lippincott Williams & Wilkins, 2023)
...
Triggers and regulation: The gut microbiome in rheumatoid arthritis
(Taylor and Francis Ltd., 2023)
Introduction Rheumatoid arthritis is a chronic inflammatory disease marked by systemic symptoms and joint degeneration. Interestingly, the development and progression of rheumatoid arthritis have been linked to the microbiome, ...
Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study
(SAGE Publications Ltd, 2023)
...
Real-life experiences with galcanezumab disclosed new predictors for response
(SAGE Publications Ltd, 2023)
...
Vascular comorbidity and cognition in migraine
(SAGE Publications Ltd, 2023)
...
The impact of single-use digital flexible cystoscope for double J removal on hospital costs and work organization: A multicentric evaluation
(SAGE Publications Ltd, 2023)
Background: Isiris-alpha (R) is a single-use digital flexible cystoscope with an integrated grasper designed for double J (DJ) stent removal. Aim of this study was to conduct a multicentric evaluation of the costs and ...
Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.
(Lippincott Williams & Wilkins, 2023)
...